The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD

Abstract In chronic obstructive pulmonary disease (COPD) apoptotic bronchial epithelial cells are increased, and their phagocytosis by alveolar macrophages (AM) is decreased alongside bacterial phagocytosis. Epithelial cellular lipids, including those exposed on uncleared apoptotic bodies, can becom...

Full description

Bibliographic Details
Main Authors: Miranda P. Ween, Jake B. White, Hai B. Tran, Violet Mukaro, Charles Jones, Matthew Macowan, Gregory Hodge, Paul J. Trim, Marten F. Snel, Sandra J. Hodge
Format: Article
Language:English
Published: Nature Publishing Group 2021-02-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-021-82481-0
id doaj-78d884c250684b168035f4d76956f5ac
record_format Article
spelling doaj-78d884c250684b168035f4d76956f5ac2021-02-21T12:35:00ZengNature Publishing GroupScientific Reports2045-23222021-02-0111111410.1038/s41598-021-82481-0The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPDMiranda P. Ween0Jake B. White1Hai B. Tran2Violet Mukaro3Charles Jones4Matthew Macowan5Gregory Hodge6Paul J. Trim7Marten F. Snel8Sandra J. Hodge9Department of Thoracic Medicine, Royal Adelaide HospitalSchool of Medicine, Faculty of Health Sciences, University of AdelaideDepartment of Thoracic Medicine, Royal Adelaide HospitalDepartment of Thoracic Medicine, Royal Adelaide HospitalSchool of Medicine, Faculty of Health Sciences, University of AdelaideDepartment of Thoracic Medicine, Royal Adelaide HospitalDepartment of Thoracic Medicine, Royal Adelaide HospitalSchool of Medicine, Faculty of Health Sciences, University of AdelaideSchool of Medicine, Faculty of Health Sciences, University of AdelaideSchool of Medicine, Faculty of Health Sciences, University of AdelaideAbstract In chronic obstructive pulmonary disease (COPD) apoptotic bronchial epithelial cells are increased, and their phagocytosis by alveolar macrophages (AM) is decreased alongside bacterial phagocytosis. Epithelial cellular lipids, including those exposed on uncleared apoptotic bodies, can become oxidized, and may be recognized and presented as non-self by antigen presenting cells. CD1b is a lipid-presenting protein, previously only described in dendritic cells. We investigated whether CD1b is upregulated in COPD AM, and whether lipid oxidation products are found in the airways of cigarette smoke (CS) exposed mice. We also characterise CD1b for the first time in a range of macrophages and assess CD1b expression and phagocytic function in response to oxidised lipid. Bronchoalveolar lavage and exhaled breath condensate were collected from never-smoker, current-smoker, and COPD patients and AM CD1b expression and airway 8-isoprostane levels assessed. Malondialdehyde was measured in CS-exposed mouse airways by confocal/immunofluorescence. Oxidation of lipids produced from CS-exposed 16HBE14o- (HBE) bronchial epithelial cells was assessed by spectrophotometry and changes in lipid classes assessed by mass spectrometry. 16HBE cell toxicity was measured by flow cytometry as was phagocytosis, CD1b expression, HLA class I/II, and mannose receptor (MR) in monocyte derived macrophages (MDM). AM CD1b was significantly increased in COPD smokers (4.5 fold), COPD ex-smokers (4.3 fold), and smokers (3.9 fold), and AM CD1b significantly correlated with disease severity (FEV1) and smoking pack years. Airway 8-isoprostane also increased in smokers and COPD smokers and ex-smokers. Malondialdehyde was significantly increased in the bronchial epithelium of CS-exposed mice (MFI of 18.18 vs 23.50 for control). Oxidised lipid was produced from CS-exposed bronchial epithelial cells (9.8-fold of control) and showed a different overall lipid makeup to that of control total cellular lipid. This oxidised epithelial lipid significantly upregulated MDM CD1b, caused bronchial epithelial cell toxicity, and reduced MDM phagocytic capacity and MR in a dose dependent manner. Increased levels of oxidised lipids in the airways of COPD patients may be responsible for reduced phagocytosis and may become a self-antigen to be presented by CD1b on macrophages to perpetuate disease progression despite smoking cessation.https://doi.org/10.1038/s41598-021-82481-0
collection DOAJ
language English
format Article
sources DOAJ
author Miranda P. Ween
Jake B. White
Hai B. Tran
Violet Mukaro
Charles Jones
Matthew Macowan
Gregory Hodge
Paul J. Trim
Marten F. Snel
Sandra J. Hodge
spellingShingle Miranda P. Ween
Jake B. White
Hai B. Tran
Violet Mukaro
Charles Jones
Matthew Macowan
Gregory Hodge
Paul J. Trim
Marten F. Snel
Sandra J. Hodge
The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD
Scientific Reports
author_facet Miranda P. Ween
Jake B. White
Hai B. Tran
Violet Mukaro
Charles Jones
Matthew Macowan
Gregory Hodge
Paul J. Trim
Marten F. Snel
Sandra J. Hodge
author_sort Miranda P. Ween
title The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD
title_short The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD
title_full The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD
title_fullStr The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD
title_full_unstemmed The role of oxidised self-lipids and alveolar macrophage CD1b expression in COPD
title_sort role of oxidised self-lipids and alveolar macrophage cd1b expression in copd
publisher Nature Publishing Group
series Scientific Reports
issn 2045-2322
publishDate 2021-02-01
description Abstract In chronic obstructive pulmonary disease (COPD) apoptotic bronchial epithelial cells are increased, and their phagocytosis by alveolar macrophages (AM) is decreased alongside bacterial phagocytosis. Epithelial cellular lipids, including those exposed on uncleared apoptotic bodies, can become oxidized, and may be recognized and presented as non-self by antigen presenting cells. CD1b is a lipid-presenting protein, previously only described in dendritic cells. We investigated whether CD1b is upregulated in COPD AM, and whether lipid oxidation products are found in the airways of cigarette smoke (CS) exposed mice. We also characterise CD1b for the first time in a range of macrophages and assess CD1b expression and phagocytic function in response to oxidised lipid. Bronchoalveolar lavage and exhaled breath condensate were collected from never-smoker, current-smoker, and COPD patients and AM CD1b expression and airway 8-isoprostane levels assessed. Malondialdehyde was measured in CS-exposed mouse airways by confocal/immunofluorescence. Oxidation of lipids produced from CS-exposed 16HBE14o- (HBE) bronchial epithelial cells was assessed by spectrophotometry and changes in lipid classes assessed by mass spectrometry. 16HBE cell toxicity was measured by flow cytometry as was phagocytosis, CD1b expression, HLA class I/II, and mannose receptor (MR) in monocyte derived macrophages (MDM). AM CD1b was significantly increased in COPD smokers (4.5 fold), COPD ex-smokers (4.3 fold), and smokers (3.9 fold), and AM CD1b significantly correlated with disease severity (FEV1) and smoking pack years. Airway 8-isoprostane also increased in smokers and COPD smokers and ex-smokers. Malondialdehyde was significantly increased in the bronchial epithelium of CS-exposed mice (MFI of 18.18 vs 23.50 for control). Oxidised lipid was produced from CS-exposed bronchial epithelial cells (9.8-fold of control) and showed a different overall lipid makeup to that of control total cellular lipid. This oxidised epithelial lipid significantly upregulated MDM CD1b, caused bronchial epithelial cell toxicity, and reduced MDM phagocytic capacity and MR in a dose dependent manner. Increased levels of oxidised lipids in the airways of COPD patients may be responsible for reduced phagocytosis and may become a self-antigen to be presented by CD1b on macrophages to perpetuate disease progression despite smoking cessation.
url https://doi.org/10.1038/s41598-021-82481-0
work_keys_str_mv AT mirandapween theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT jakebwhite theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT haibtran theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT violetmukaro theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT charlesjones theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT matthewmacowan theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT gregoryhodge theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT pauljtrim theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT martenfsnel theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT sandrajhodge theroleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT mirandapween roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT jakebwhite roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT haibtran roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT violetmukaro roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT charlesjones roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT matthewmacowan roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT gregoryhodge roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT pauljtrim roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT martenfsnel roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
AT sandrajhodge roleofoxidisedselflipidsandalveolarmacrophagecd1bexpressionincopd
_version_ 1724257927856914432